Molbio Diagnostics Ltd
NSE: MOLBIO · Medical Equipment & Supplies · sector
₹1,273.50NSE close 2026-10-26
Key numbers
Market cap₹14,360 cr
Price₹1,273.50
52w high / low₹1,687 / ₹926
P/E–Sector median 20.2x
P/B–Sector median 2.6x
Book value₹–
Dividend yield–Sector median 0.24%
ROE–Sector median 12.4%
ROCE–Sector median 13.5%
OPM–Sector median 13.8%
Debt / equity–Sector median 0.13x
EV/EBITDA–Sector median 16.4x
Interest cover–
Current ratio–
Sales growth 3y–Sector median +12.9%
Profit growth 3y–Sector median +4.1%
PEG–
Last 12 months to Jun 2026, Consolidated. "Sector median" = middle value of 15 companies in Medical Equipment & Supplies (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Price ₹1,273.50 on 2026-10-26: -24.5% from the 52-week high, +37.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Weekly close · high ₹1,574.40 · low ₹1,036.65
RevenueNet profit
Quarterly results
| ₹ cr | Jun 2026 |
|---|---|
| Revenue | 408 |
| EBITDA | 101 |
| OPM % | 24.6% |
| Other income | 3 |
| Net profit | 59 |
| EPS (₹) | 5.21 |
Consolidated figures where filed. Latest quarter Jun 2026.
Profit & loss (yearly)
| ₹ cr | TTM |
|---|---|
| Revenue | – |
| EBITDA | – |
| Net profit | – |
| EPS (₹) | – |
| Dividend / share (₹) |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | – | – | – |
| Net profit | – | – | – |
| EPS | – | – | – |
| Share price | – | – (2y) | – |
Shareholding
| Holder | % (2026-09-30) |
|---|---|
| Promoters | 41.29% |
| FIIs | 1.59% |
| DIIs | 19.08% |
| of which Mutual funds | 8.03% |
| of which Insurance | 0.47% |
| Public (non-institutions) | 38.03% |
| Quarter | Aug 2026 | Sep 2026 |
|---|---|---|
| Promoters % | 41.29% | 41.29% |
| Promoter group | % |
|---|---|
| Exxora Trading LLP | 37.05% |
| Chandrasekhar Bhaskaran Nair | 4.24% |
| Sriram Natarjan | 0.00% |
| Sangeetha Sriram | 0.00% |
| Shiva Sriram | 0.00% |
| Sowmya Sriram | 0.00% |
| Sheebani Shiva Sriram | 0.00% |
| Neelesh Pissurlencar | 0.00% |
| Tripti Pissurlencar | 0.00% |
| Shalaka Pissurlencar | 0.00% |
| Gaurav Bali | 0.00% |
| Amyra Bali | 0.00% |
| Pushpa Bali | 0.00% |
| Seema Verma | 0.00% |
| Anita A Chandrasekhar | 0.00% |
| Public holders above 1% | % |
|---|---|
| Business Excellence Trust III - India Business EXC | 8.92% |
| V-sciences Investments PTE Ltd | 8.74% |
| Kini Gopalkrishna Mangalore | 5.61% |
| Kotak Aggressive Hybrid Fund | 4.99% |
| Gopalakrishna Sampathgiri | 4.52% |
| Javagal Guru Dutt | 4.48% |
| Usha Rani M A | 2.45% |
| Sangeetha Mangalore Kini | 2.26% |
| Rohit Mullangi Ashok Kumar | 1.45% |
| Shruthi G Kini | 1.09% |
50,395 shareholders. Pledged: – of promoter shares.
Peers in Medical Equipment & Supplies
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| POLYMED | ₹14,631 cr | 46.4x | 4.7x | 10.7% | 12.7% | 22.8% | +18.9% | 0.24% |
| MOLBIO | ₹14,360 cr | – | – | – | – | – | – | – |
| TARSONS | ₹1,587 cr | 142.7x | 2.5x | 1.8% | 4.1% | 26.8% | +14.3% | – |
| LAXMIDENTL | ₹945 cr | 30.4x | 3.9x | 13.7% | 13.4% | 14.0% | – | – |
| FISCHER | ₹856 cr | 11.2x | 2.2x | -0.8% | 11.6% | 13.6% | – | 0.04% |
| HSIL | ₹740 cr | 36.9x | 6.5x | 21.8% | 24.1% | 10.0% | – | – |
| FABTECH | ₹543 cr | 8.8x | 1.3x | 11.6% | 13.6% | 10.9% | – | – |
| PREVEST | ₹455 cr | 14.7x | 4.0x | 29.9% | 36.9% | 34.1% | +12.9% | 0.26% |
| NURECA | ₹296 cr | 63.0x | 1.6x | 2.5% | 5.3% | 3.5% | +9.7% | – |
| CHOKSI | ₹115 cr | 22.2x | 2.7x | 13.1% | 17.9% | 14.5% | +300.1% | – |
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Medical Equipment & Supplies |
| Sub-industry | Medical Equipment & Supplies |
| Symbol | MOLBIO |
| BSE code | 544866 |
| ISIN | INE869T01028 |
| Face value | ₹1.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-22 from NSE company filings (XBRL: Integrated Filing - Financials + financial results), NSE shareholding & pledge data; price = NSE close 2026-10-26.